Generation Capital Management’s AbbVie ABBV Stock Holding History

Generation Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$461K	Hold	1,830	–	–	0.28%	64
2026 Q1	$398K	Sell	1,830 -2	-0.1%	-$444	0.29%	57
2025 Q4	$419K	Buy	1,832 +2	+0.1%	+$456	0.27%	63
2025 Q3	$424K	Hold	1,830	–	–	0.31%	60
2025 Q2	$340K	Buy	1,830 +115	+7%	+$21.4K	0.27%	62
2025 Q1	$359K	Sell	1,715 -160	-9%	-$31.1K	0.32%	55
2024 Q4	$333K	Buy	+1,875	New	+$345K	0.29%	61

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Generation Capital Management's ABBV Position: Q2 2026 in Review

Generation Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,830 shares worth $461K. The position accounts for 0.28% of the portfolio, ranked #64.

Generation Capital Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Generation Capital Management held 1,830 shares of AbbVie worth $461K as of Q2 2026.
Generation Capital Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.28% of Generation Capital Management's portfolio in Q2 2026, its #64 holding.
Generation Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Generation Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.